Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

The purpose of this study is to assess the safety and effectiveness of vildagliptin, an unapproved drug, compared to placebo in lowering post-meal blood glucose levels in people with pre-diabetes who have high blood sugar levels after meals.

• Change in area under the 0-2 hour prandial glucose curve at 12 weeks

1. Last registry update

   May 7, 2012

2. Primary completion

   Jul 2006

3. Started

   Oct 2005

4. Registered

   Oct 12, 2005